AACVPR indicates American Association of Cardiovascular and Pulmonary Rehabilitation; ACC, American College of Cardiology; ACCF, American College of Cardiology Foundation; AHA, American Heart Association; AMI, acute myocardial infarction; FDA, US Food and Drug Administration; HIPAA, the Health Insurance Portability and Accountability Act; LVEF, left ventricular ejection fraction; NSTEMI, non ST-elevation myocardial infarction; NSTE-ACS, non ST-segment elevation acute coronary syndromes; PM, performance measure; and STEMI, ST-elevation myocardial infarction. 8 Table 6. New STEMI/NSTEMI Measures No. Care Setting Measure Title Rationale for Creating New Measure Rationale for Designating as a Quality Measure as Opposed to a Performance Measure (If Applicable) PM-14 Inpatient Immediate Angiography for Resuscitated Out- of-Hospital Cardiac Arrest in STEMI Patients This measure seeks to implement a Class I (Level of Evidence B) recommendation in the 2013 ACCF/AHA STEMI guideline12 that immediate angiography with PCI when indicated should be performed in resuscitated out-of-hospital cardiac arrest patients whose initial ECG shows STEMI. The writing committee opted to include angiography only, which is easily measurable, and not PCI because of the difficulty associated with ascertaining PCI appropriateness or its lack thereof. Not Applicable PM-15 Inpatient Noninvasive Stress Testing Before Discharge in Conservatively Treated Patients This measure seeks to implement Class I (Level of Evidence B) recommendations in both the guidelines to perform noninvasive stress testing to detect inducible ischemia in medically treated STEMI and NSTEMI patients. Not Applicable PM-16 Inpatient Early Cardiac Troponin Measurement (Within 6 Hours of Arrival) This measure seeks to implement Class I (Level of Evidence A) recommendations in the 2014 AHA/ACC NSTE-ACS guideline11 to measure serial cardiac troponin levels (at presentation and 3 to 6 h after symptom onset in all patients). 